Načítá se...
Pharmacology and rationale for imatinib in the treatment of scleroderma
Systemic sclerosis (scleroderma) is a chronic, multisystem, fibrotic disease. Although the pathogenesis is not completely understood, early vascular damage leads to an inflammatory reaction and a severe fibrotic response. Therapy of systemic sclerosis is still not convincing and is mainly restricted...
Uloženo v:
| Vydáno v: | J Exp Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4863537/ https://ncbi.nlm.nih.gov/pubmed/27186133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S26894 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|